UPDATED Aug 14, 2025
Discover Egyptian Pharmaceuticals & Biotech Growth Stocks that are on the CASE/EGX. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
RMDA | ج.م4.33 | -4.4% | 83.5% | ج.م6.5b | ج.م7.58 | PE15.7x | E28.6% | 1.2% | ||
PHAR | ج.م52.30 | 2.4% | 38.3% | ج.م8.8b | ج.م90.00 | PE7.8x | E23.4% | 2.9% | ||
ADCI | ج.م140.00 | 9.5% | 241.5% | ج.م1.7b | n/a | PE10.6x | n/a | 3.0% | ||
NIPH | ج.م46.10 | -23.1% | -32.2% | ج.م466.8m | n/a | PE5x | n/a | 8.0% | ||
OCPH | ج.م150.40 | 20.0% | 50.4% | ج.م1.8b | n/a | PE13x | n/a | 1.7% | ||
MIPH | ج.م238.57 | 0.3% | 32.4% | ج.م2.8b | n/a | PE17x | n/a | 1.0% | ||
AXPH | ج.م675.69 | 4.9% | 208.2% | ج.م3.4b | n/a | PE11x | n/a | 4.4% | ||
MPCI | ج.م122.08 | 14.1% | 264.0% | ج.م2.8b | n/a | PE6.9x | n/a | 3.3% | ||
CPCI | ج.م216.99 | 9.4% | 196.2% | ج.م3.2b | n/a | PE8x | n/a | 5.9% | ||
BIOC | ج.م48.48 | 0.3% | 70.2% | ج.م4.0b | n/a | PE27.6x | n/a | 1.5% | ||
SIPC | ج.م3.88 | 7.5% | 396.8% | ج.م970.0m | n/a | PS29.5x | n/a | 0% |